Home LiteratureArticle Details
PMID: 14528048 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S. Review

Overview of protein aggregation in single, double, and triple neurodegenerative brain amyloidoses.

Neuromolecular medicine ·Vol. 4 ·No. 1-2 ·2003-00-00 ·Pages 1-6

Trojanowski JQ, Mattson MP

Abstract

暂无摘要

MeSH Terms
Amyloid beta-Peptides/genetics,metabolism Animals Humans Mutation/genetics Nerve Tissue Proteins/genetics,metabolism Neurodegenerative Diseases/genetics,metabolism,physiopathology Neurofibrillary Tangles/genetics,metabolism,pathology Plaque, Amyloid/genetics,metabolism,pathology Synucleins tau Proteins/genetics,metabolism
Chemicals
Amyloid beta-Peptides Nerve Tissue Proteins Synucleins tau Proteins
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Trojanowski John Q
Department of Pathology and Laboratory Medicine, Institute on Aging, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA. [email protected]
Mattson Mark P
References (23)
23 references, click to expand
  1. Chaperoning brain diseases.
    Nature. 1998 Mar 5;392(6671):23-4 PMID: 9510241
  2. Initiation and synergistic fibrillization of tau and alpha-synuclein.
    Science. 2003 Apr 25;300(5619):636-40 PMID: 12714745
  3. Chaperone suppression of alpha-synuclein toxicity in a Drosophila model for Parkinson's disease.
    Science. 2002 Feb 1;295(5556):865-8 PMID: 11823645
  4. "Fatal attractions" of proteins. A comprehensive hypothetical mechanism underlying Alzheimer's disease and other neurodegenerative disorders.
    Ann N Y Acad Sci. 2000;924:62-7 PMID: 11193803
  5. Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases.
    Nature. 2002 Apr 4;416(6880):507-11 PMID: 11932737
  6. Chaperoning brain degeneration.
    Proc Natl Acad Sci U S A. 2002 Dec 10;99 Suppl 4:16407-11 PMID: 12149445
  7. Treatment of Alzheimer's disease.
    N Engl J Med. 1999 Nov 25;341(22):1670-9 PMID: 10572156
  8. Alzheimer's disease-do tauists and baptists finally shake hands?
    Trends Neurosci. 2002 Jan;25(1):22-6 PMID: 11801334
  9. Amyloid deposition as the central event in the aetiology of Alzheimer's disease.
    Trends Pharmacol Sci. 1991 Oct;12(10):383-8 PMID: 1763432
  10. Parkinson's disease and related alpha-synucleinopathies are brain amyloidoses.
    Ann N Y Acad Sci. 2003 Jun;991:107-10 PMID: 12846979
  11. Genetic dissection of Alzheimer's disease and related dementias: amyloid and its relationship to tau.
    Nat Neurosci. 1998 Sep;1(5):355-8 PMID: 10196523
  12. "Emerging Alzheimer's disease therapies: focusing on the future".
    Neurobiol Aging. 2002 Nov-Dec;23(6):985-90 PMID: 12470793
  13. Toxic proteins in neurodegenerative disease.
    Science. 2002 Jun 14;296(5575):1991-5 PMID: 12065827
  14. Application of chemical chaperones to the rescue of folding defects.
    Methods Mol Biol. 2003;232:231-43 PMID: 12840553
  15. Neurodegenerative tauopathies.
    Annu Rev Neurosci. 2001;24:1121-59 PMID: 11520930
  16. Amyloid, the presenilins and Alzheimer's disease.
    Trends Neurosci. 1997 Apr;20(4):154-9 PMID: 9106355
  17. Modification of brain aging and neurodegenerative disorders by genes, diet, and behavior.
    Physiol Rev. 2002 Jul;82(3):637-72 PMID: 12087131
  18. The relationship between oxidative/nitrative stress and pathological inclusions in Alzheimer's and Parkinson's diseases.
    Free Radic Biol Med. 2002 Jun 15;32(12):1264-75 PMID: 12057764
  19. Unfolding the role of protein misfolding in neurodegenerative diseases.
    Nat Rev Neurosci. 2003 Jan;4(1):49-60 PMID: 12511861
  20. Oxidative damage linked to neurodegeneration by selective alpha-synuclein nitration in synucleinopathy lesions.
    Science. 2000 Nov 3;290(5493):985-9 PMID: 11062131
  21. Pharmacological prevention of Parkinson disease in Drosophila.
    Nat Med. 2002 Nov;8(11):1185-6 PMID: 12411925
  22. Alzheimer disease therapeutics.
    J Neuropathol Exp Neurol. 2001 Oct;60(10):923-8 PMID: 11589422
  23. Excitotoxic and excitoprotective mechanisms: abundant targets for the prevention and treatment of neurodegenerative disorders.
    Neuromolecular Med. 2003;3(2):65-94 PMID: 12728191
Article Info
Journal
Neuromolecular medicine
Abbr.
Neuromolecular Med
ISSN
1535-1084
DOI
10.1385/NMM:4:1-2:1
Email
[email protected]
Published
2003-00-00
Pages
1-6
Language
English
Region
United States
NLM ID
101135365
Subset
IM
External Links
PubMed source DOI: 10.1385/NMM:4:1-2:1 View journal details
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]

Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2